ArticleNigerian medical journal : journal of the Nigeria Medical Association
Paraneoplastic Anti-NMDA Receptor Encephalitis in a Nigerian Female Teenager: A Case Report.
Article in Nigerian medical journal : journal of the Nigeria Medical Association. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis is characterized by neuropsychiatric symptoms, seizures, dysautonomia, and movement disorders. Initially identified as a paraneoplastic syndrome predominantly in young women with ovarian teratomas, it has become clear that not all affected individuals have tumors, and symptoms can occur across genders. With the availability of the NMDAR antibody assay, cases have also been identified in patients presenting with early psychosis, epilepsy, and classic limbic encephalitis. This emerging understanding enables earlier diagnosis, even in resource-limited settings, facilitating a multidisciplinary management approach that combines immunotherapies and tumor removal when indicated. This case highlights the importance of recognizing anti-NMDAR encephalitis in an 18-year-old female, emphasizing the need for prompt intervention to improve recovery outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.